Efficient DNA Condensation by a C₃ -Symmetric Codeine Scaffold.

Area of Science:

• Medicinal Chemistry
• Biochemistry
• Nanotechnology

Background:

• DNA condensation is crucial for efficient gene therapy delivery.
• Existing DNA condensing agents face limitations in handling large DNA plasmids.
• Alkaloids offer a unique structural basis for developing novel biomaterials.

Purpose of the Study:

• To design and characterize a novel tripodal codeine scaffold (CC3) as a DNA condensing agent.
• To evaluate CC3's ability to aggregate and stabilize large DNA plasmids.
• To explore CC3's potential applications in gene therapy.

Main Methods:

• Computational design of the tripodal codeine scaffold (CC3).
• Protonation studies at physiological pH to assess DNA binding and release.
• Zeta potential and Atomic Force Microscopy (AFM) for particle characterization.

Main Results:

• CC3 exhibits a larger piperidine nitrogen separation (14.36 Å) enabling aggregation of large DNA plasmids (>4,000 bp).
• Protonation at physiological pH allows controlled DNA compaction and release, tunable by ionic strength.
• AFM revealed condensed particle sizes with a height of 103 nm and diameter of 350 nm, stabilized at low alkaloid loading.

Conclusions:

• CC3 is a novel alkaloid-based DNA condensing agent with enhanced capacity for large DNA plasmids.
• The scaffold's pH-dependent properties enable controlled nucleic acid delivery.
• CC3 shows significant potential for gene therapy applications due to its DNA condensation capabilities.